Journal Article

Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORM

  • Heipertz A
  • Pajtler K
  • Pfaff E
  • et al.
JCO Precision Oncology (2023) (7)
DOI: 10.1200/po.23.00015
30Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Outcomes of children with high-risk malignancies receiving matched targeted treatment in the INFORM registry.

Cite

CITATION STYLE

APA

Heipertz, A.-E., Pajtler, K. W., Pfaff, E., Schramm, K., Blattner-Johnson, M., Milde, T., … van Tilburg, C. M. (2023). Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORM. JCO Precision Oncology, (7). https://doi.org/10.1200/po.23.00015

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free